4113.TWO We&Win Diversification Co Ltd
- Market cap
- TWD 2.99B
- P/E
- -
- P/B
- 0.72x
- ROE
- -5.1%
- Dividend yield
- 6.56%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 4113.TWO undervalued?
Graham numberThe Graham number of We&Win Diversification Co Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
We&Win Diversification Co Ltd fundamental analysis
No fundamental analysis for We&Win Diversification Co Ltd yet.
We&Win Diversification Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About We&Win Diversification Co Ltd
We & Win Diversification Co., Ltd. engages in the rental and sale of real estate properties in Taiwan. It is also involved in the public facilities construction investment; new towns and community development; wholesale of medical equipment; and international trade businesses. The company was formerly known as Oncoprobe Biotech Inc. and changed its name to We & Win Diversification Co., Ltd. in 2009. We & Win Diversification Co., Ltd. was founded in 1987 and is based in Kaohs…
Full company profileWe&Win Diversification Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
We&Win Diversification Co Ltd annual financial statements (TWD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 880M | 1.96B | 978M | 220M | 1.44B | 86.5M | 518M | 5.72B | 610M | 376M |
| Gross Profit | 244M | 355M | 248M | 45.4M | 364M | 27.4M | 109M | 1.52B | 125M | 73.2M |
| Operating Income | 125M | 217M | 120M | -41.8M | 203M | -70.4M | -47.3M | 1.04B | -2.54M | -49.4M |
| EBITDA | 131M | 206M | -73.0M | -38.2M | 209M | -63.5M | -40.3M | 1.06B | 30.4M | -72.1M |
| Net Income | 85.4M | 145M | -144M | -106M | 134M | -144M | -146M | 771M | -100M | -212M |
| EPS | 0.40 | 0.69 | -0.68 | -0.50 | 0.63 | -0.68 | -0.69 | 3.33 | -0.43 | -0.92 |
| Balance Sheet | ||||||||||
| Total Assets | 7.78B | 8.43B | 8.97B | 11.9B | 12.6B | 14.0B | 15.3B | 13.2B | 15.8B | 16.6B |
| Total Liabilities | 4.17B | 4.70B | 5.44B | 8.44B | 9.12B | 10.8B | 12.2B | 8.68B | 11.6B | 12.4B |
| Shareholders' Equity | 3.61B | 3.73B | 3.52B | 3.42B | 3.49B | 3.26B | 3.11B | 4.52B | 4.27B | 4.18B |
| Cash & Short-term Investments | 82.7M | 113M | 287M | 975M | 1.16B | 855M | 630M | 1.06B | 162M | 313M |
| Total Debt | - | - | - | 6.71B | 7.03B | 8.47B | 9.35B | - | - | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | -400M | 145M | 522M | -1.89B | 141M | -1.50B | -937M | 2.22B | -2.92B | -807M |
| Capital Expenditure | 2.29M | 2.29M | 2.29M | 2.29M | 161K | 56.3M | 33.4M | 10.2M | 9.16M | 0.00 |
| Free Cash Flow | -400M | 145M | 522M | -1.89B | 141M | -1.55B | -971M | 2.21B | -2.93B | -820M |
| Ratios | ||||||||||
| ROE | 2.4% | 3.9% | -4.1% | -3.1% | 3.8% | -4.4% | -4.7% | 17.0% | -2.3% | -5.1% |
| ROA | 1.1% | 1.7% | -1.6% | -0.9% | 1.1% | -1.0% | -0.9% | 5.8% | -0.6% | -1.3% |
| Net Profit Margin | 9.7% | 7.4% | -14.7% | -48.1% | 9.3% | -166.6% | -28.1% | 13.5% | -16.4% | -56.4% |
| Debt to Equity | - | - | - | 1.96x | 2.01x | 2.60x | 3.00x | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
We&Win Diversification Co Ltd dividends
- Dividend yield
- 6.56%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Aug 28, 2025
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | TWD 196M | 0.85 | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | TWD 84.5M | 0.40 | - |
| 2021 | TWD 63.3M | 0.30 | 47.4% |
| 2020 | TWD 63.3M | 0.30 | - |
| 2019 | TWD 64.2M | 0.30 | - |
| 2018 | TWD 23.0M | 0.11 | 15.8% |
| 2017 | TWD 26.4M | 0.13 | 30.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1026.115:1000 on Sep 21, 2018.
Who owns We&Win Diversification Co Ltd
- Insiders 52.83%
- Institutions 0.43%
- Public & others 46.74%
- Shares outstanding 231M
- Free float 129M
We&Win Diversification Co Ltd company profile
- Company name
- We&Win Diversification Co Ltd
- Ticker
- 4113.TWO
- ISIN
- TW0004113006
- Exchange
- Taiwan OTC Exchange
- Sector
- Industrials
- Industry
- Construction & Engineering
- Employees
- 35
- Fiscal year end
- December
- Address
- No. 185, Fuguo Road, Kaohsiung, Taiwan
- Phone
- 886 7 557 5242
- Website
- kh.vvvvv.com.tw
About We&Win Diversification Co Ltd
We & Win Diversification Co., Ltd. engages in the rental and sale of real estate properties in Taiwan. It is also involved in the public facilities construction investment; new towns and community development; wholesale of medical equipment; and international trade businesses. The company was formerly known as Oncoprobe Biotech Inc. and changed its name to We & Win Diversification Co., Ltd. in 2009. We & Win Diversification Co., Ltd. was founded in 1987 and is based in Kaohsiung, Taiwan.
We&Win Diversification Co Ltd management
5- Mr. Yung-Yi SuChairman of The Board of Directors, President & GM · born 1966
- Ms. Mei-Li LinAVP of Finance Department & Account Manager
- Mr. Xin-Jie LuChief Information Security Officer
- Mr. Sheng-Wen ZhengVice GM & Director
- Ms. Nai-Chi KungCorporate Governance Officer